Adjunct Assistant Professor of Strategy
Matthew Schmitt is a health and industrial organization economist whose research examines competition and antitrust issues in health care markets, an area of growing policy interest. Schmitt’s current projects include studies of competition between multihospital systems, cost savings from hospital mergers, copayment coupons for prescription drugs and “reverse payment” patent settlements.
Is Anyone Happy about the College Textbook Market?
Buyers find the tomes heavy, costly and too frequently revised, while sellers might like to kill the used book market entirely
Some Corporate Mergers Hold Down Future Wages
Fewer employers = less competition for workers = smaller paychecks
Exploring the Relationship between Off-Label Prescriptions and Clinical Trials
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
How Antitrust Thinking on Hospital Mergers Has Been Forced to Evolve
Matt Schmitt’s research shows hospital prices rise after acquisitions, even where local competition is unchanged
Do Hospital Mergers Really Cut Health Care Costs?
Matt Schmitt finds that size and location help determine how much, if any, costs fall after deals